Member Info for Digger01

Capital required in order to create liquidity and facilitate US trials for Oncohist. Erepoxen out licensing will be used as a carrot for this and will hopefully come to fruition by mid next year IMHO. We are surely looking at a minimum of 50 million shares going into the pot in order to raise $20 million ? or is my guess wild ? Any other thoughts for discussion ?

Are we due a quarterly business update very soon ? I note that the first quarter was published 21/05/14, so IF Scott has anything to report, we might get some crumbs off the table soon. Will his lordship be attending the banquet ?

Good design model but we need wheels ! All quiet with no hints from any source ? - clearly substantial capital raising may well be linked to any Nasdaq listing UNLESS Scott can land a great licensing deal for Erepoxen with a sizeable upfront payment ?

Restore upbeat tranquility to the board ! Where is our resident Joker Leeson these days ? Come on Lordy exercise some aristocratic authority and keep the Xenites in order. We only need 1000 trade volume to put this back to $1 but that is not really of any significance ! We need Nasdaq and Eropoxen out Licencing. Patience my friends.

Did anyone think that the RNS relating to the AUS results was a bit low key considering the implied importance ? I am just looking for reasons to get excited - relating to this company of course.

Spelling just in case you thought is was a competitor's product.

Anyone have any idea what Scott is up to ? What is the next news which will help our mission ? Do we have enough data for Ereopexen to tempt a Pharma or is it still too early.? Oncohist ?

Yes the goal and mission are clear but the path is a bit misty and I am not sure where we are in distance terms along that path. However, as you say, so far so good. Patience !

Good morning all - So what is the general opinion on the Aus results which seemed a bit "matter of fact in the last RNS" - Are they good, great - as expected etc etc ?? are they the results which actually now put us in a strong negotiating position for an out licence deal ? which must be the main driver on the road to Nasdaq ? is there anything else expected in the "near future" - am I missing something very exciting ?

Good finds. I am sure that the puzzle is coming together, just hope it starts to unfold soon. Good ERepoxen results from Aus are a must.

A great price to pick up a few shares M' Lord

Another patent to ensure that we are well covered before release of data from Aus. Puts us in a stronger position for out licensing as interested parties will make sure that they / we are protected. Scott mentioned in the conference call that the data will come out this month and it would seem that this will be a platform to bring in ii within the US providing a foundation for Nasdaq up-lift. Exciting times are close one feels.

If Lordy paid a good working wage, I would be buying those 8K shares for $0.55 !

One appreciates the trouble that his lordship has gone to by informing his loyal subjects of such things.

Its Tomorrow.

Has anybody taken part ? / Listened today

Sorry but missed it - hence my question.

Did anyone get a chance to listen to today's presentation ?

Looks like we are after investment - interesting that attendance presentations are by invitation only. Live webcast link on RNS - 4.30pm UK time today

In the news schedule ? Especially Eropoxen Aus update.